Emerging data suggest Retatrutide , a dual activator targeting both GLP-1 and GIP , could represent a significant step forward for weight management . Early clinical investigations have demonstrated https://getretatrutideaustralia.com/blog/retatrutide-vs-tirzepatide-semaglutide